UB Paderborn / Katalog / Suche / in CDI

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment

Neurology, 2007-05, Vol.68 (19), p.1603

2007

Link zum Volltext

Verfügbarkeit prüfen

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease

Neurology, 2006-11, Vol.67 (9), p.1575

2006

Link zum Volltext

Verfügbarkeit prüfen

Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients

European journal of neurology, 2013-07, Vol.20 (7), p.1043-1052

2013

Link zum Volltext

Verfügbarkeit prüfen

Reminders of Drug Effects on Laboratory Test Results

Clinical chemistry (Baltimore, Md.), 2000-09, Vol.46 (9), p.1395-1400

2000

Link zum Volltext

Verfügbarkeit prüfen

Night-time bioavailability of levodopa/carbidopa/entacapone is higher compared to controlled-release levodopa/carbidopa

International journal of clinical pharmacology and therapeutics, 2010-11, Vol.48 (11), p.756

2010

Link zum Volltext

Verfügbarkeit prüfen

Assessment of MAO‐B Occupancy in the Brain With PET and [11C]‐L‐Deprenyl‐D2: A Dose‐Finding Study With a Novel MAO‐B Inhibitor, EVT 301

Clinical pharmacology and therapeutics, 2009-05, Vol.85 (5), p.506-512

2009

Link zum Volltext

Verfügbarkeit prüfen

Early effects of 5-fluorouracil, epirubicin and cyclophosphamide therapy on common laboratory tests

Anticancer research, 2001-07, Vol.21 (4B), p.2867

2001

Link zum Volltext

Verfügbarkeit prüfen

Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids

Anticancer research, 2000-03, Vol.20 (2B), p.1323

2000

Link zum Volltext

Verfügbarkeit prüfen

Frequency and clinical outcome of potentially harmful Drug metabolic interactions in patients hospitalized on internal and pulmonary medicine wards : Focus on warfarin and cisapride

Therapeutic drug monitoring, 2000-10, Vol.22 (5), p.503-509

2000

Link zum Volltext

Verfügbarkeit prüfen

Alterations in Laboratory Test Results during Adjuvant Breast Cancer Treatment

Clinical chemistry and laboratory medicine, 2000-05, Vol.38 (5), p.443-451

2000

Link zum Volltext

Verfügbarkeit prüfen

Serum cholesterol, HDL cholesterol and triglycerides during adjuvant CMF therapy in premenopausal breast cancer patients

European journal of cancer (1990), 1999-09, Vol.35, p.S210-S210

1999

Link zum Volltext

Verfügbarkeit prüfen

Support to clinician's decision making--automatic comments about drug effects on laboratory results

Duodecim (Helsinki, Finland : 1961), 1998, Vol.114 (14), p.1387

1998

Link zum Volltext

Verfügbarkeit prüfen

Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti‐inflammatory drug: A randomized, placebo‐controlled, double‐blind clinical trial

British journal of clinical pharmacology, 2021-12, Vol.87 (12), p.4625-4635

2021

Link zum Volltext

Verfügbarkeit prüfen

Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain

European journal of nuclear medicine and molecular imaging, 2015-01, Vol.42 (1), p.120

2015

Link zum Volltext

Verfügbarkeit prüfen

C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men

European journal of nuclear medicine and molecular imaging, 2014-10, Vol.41 (10), p.1947

2014

Link zum Volltext

Verfügbarkeit prüfen

Test–retest reliability of 11C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain

European journal of nuclear medicine and molecular imaging, 2015, Vol.42 (1), p.120-127

2015

Link zum Volltext

Verfügbarkeit prüfen

Test-retest reliability of ^sup 11^C-ORM-13070 in PET imaging of [alpha]^sub 2C^-adrenoceptors in vivo in the human brain

European journal of nuclear medicine and molecular imaging, 2015-01, Vol.42 (1), p.120

2015

Link zum Volltext

Verfügbarkeit prüfen

11C-ORM-13070, a novel PET ligand for brain α2C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men

European journal of nuclear medicine and molecular imaging, 2014-10, Vol.41 (10), p.1947-1956

2014

Link zum Volltext

Verfügbarkeit prüfen

sup 11^C-ORM-13070, a novel PET ligand for brain [alpha]^sub 2C^-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men

European journal of nuclear medicine and molecular imaging, 2014-10, Vol.41 (10), p.1947

2014

Link zum Volltext

Verfügbarkeit prüfen

Serum Bone Markers in Breast Cancer Patients During 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) Therapy

Anticancer research, 2004-03, Vol.24 (2C), p.1271-1274

2004

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data

European journal of nuclear medicine and molecular imaging, 2009-10, Vol.36 (10), p.1651-1660

2009

Link zum Volltext

Verfügbarkeit prüfen

IC-P2-133: Reproducibility of automated ROI analysis of PET amyloid ligand [11C]PIB uptake

Alzheimer's & dementia, 2008-07, Vol.4 (4), p.T60-T60

2008

Link zum Volltext

Verfügbarkeit prüfen

P2-073: Reproducibility of automated ROI analysis of PET amyloid ligand [11C]PIB uptake

Alzheimer's & dementia, 2008-07, Vol.4 (4), p.T389-T389

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease

Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients

Reminders of Drug Effects on Laboratory Test Results

Night-time bioavailability of levodopa/carbidopa/entacapone is higher compared to controlled-release levodopa/carbidopa

Assessment of MAO‐B Occupancy in the Brain With PET and [11C]‐L‐Deprenyl‐D2: A Dose‐Finding Study With a Novel MAO‐B Inhibitor, EVT 301

Early effects of 5-fluorouracil, epirubicin and cyclophosphamide therapy on common laboratory tests

Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids

Frequency and clinical outcome of potentially harmful Drug metabolic interactions in patients hospitalized on internal and pulmonary medicine wards : Focus on warfarin and cisapride

Alterations in Laboratory Test Results during Adjuvant Breast Cancer Treatment

Serum cholesterol, HDL cholesterol and triglycerides during adjuvant CMF therapy in premenopausal breast cancer patients

Support to clinician's decision making--automatic comments about drug effects on laboratory results

Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti‐inflammatory drug: A randomized, placebo‐controlled, double‐blind clinical trial

Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain

C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men

Test–retest reliability of 11C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain

Test-retest reliability of ^sup 11^C-ORM-13070 in PET imaging of [alpha]^sub 2C^-adrenoceptors in vivo in the human brain

11C-ORM-13070, a novel PET ligand for brain α2C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men

sup 11^C-ORM-13070, a novel PET ligand for brain [alpha]^sub 2C^-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men

Serum Bone Markers in Breast Cancer Patients During 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) Therapy

Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data

IC-P2-133: Reproducibility of automated ROI analysis of PET amyloid ligand [11C]PIB uptake

P2-073: Reproducibility of automated ROI analysis of PET amyloid ligand [11C]PIB uptake

Suchergebnisse filtern